Xanax (alprazolam) is typically detectable in urine for up to 5 days after use, though the window can be shorter or longer depending on several personal factors. After a single therapeutic dose, one study found a median detection time of just 36 hours in urine, with a range of 26 to 61 hours across participants. Heavier or prolonged use extends that window considerably.
Detection Window After a Single Dose
A controlled study that gave participants a single oral dose of alprazolam and then tracked their urine found the drug’s primary breakdown product was detectable for a median of 36 hours. The range across individuals was 26 to 61 hours, meaning some people cleared it in just over a day while others still showed positive results after two and a half days. This was measured using confirmation testing, which is more precise than the initial screening most labs use first.
For people who take Xanax regularly or at higher doses, the drug and its metabolites accumulate in the body. In those cases, urine screens can return a positive result for up to 5 days after the last dose, and possibly longer for very heavy, long-term users. The more alprazolam your body has stored, the longer it takes to flush out.
How Your Body Processes Xanax
Your liver breaks alprazolam down into a metabolite called alpha-hydroxyalprazolam, which is actually what most urine tests detect. The speed of this process depends on the drug’s half-life, which is the time it takes your body to eliminate half of a dose. In healthy adults, alprazolam’s average half-life is about 11.2 hours, with a range of 6.3 to 26.9 hours. As a rough rule, it takes about five half-lives for a drug to be essentially gone from your bloodstream, which puts total clearance somewhere between 1.5 and 5.5 days for most people.
But blood clearance and urine detection aren’t the same thing. Metabolites linger in urine after the drug itself has left your blood, which is why a urine test can still pick up traces even when you no longer feel any effects.
Factors That Extend Detection Time
Several biological variables shift how quickly your body clears alprazolam, and the differences can be dramatic.
Age: Older adults process Xanax significantly more slowly. FDA data shows the average half-life in healthy elderly subjects is 16.3 hours compared to 11.0 hours in younger adults. That alone can add a day or more to the detection window.
Liver health: Because the liver does the heavy lifting in breaking down alprazolam, any liver impairment slows the process. In people with alcoholic liver disease, the half-life averaged 19.7 hours but ranged as high as 65.3 hours. At that upper extreme, the drug could take over 13 days to fully clear, which would substantially extend urine detection.
Body weight: In study participants classified as obese, the average half-life nearly doubled to 21.8 hours, with a range topping out at 40.4 hours. Fat tissue can store the drug and release it slowly, keeping metabolite levels in urine elevated for longer.
Ethnicity: FDA labeling notes that peak blood concentrations and half-life of alprazolam are roughly 15% and 25% higher, respectively, in Asian individuals compared to Caucasian individuals.
Dose and frequency: A one-time low dose clears much faster than weeks of daily use. Chronic use leads to accumulation in body tissues, meaning there’s simply more drug to metabolize once you stop.
What the Test Actually Measures
Standard workplace and clinical drug panels use an immunoassay as a first pass. The recommended screening cutoff for benzodiazepines is 100 ng/mL. If your urine concentration of benzodiazepine metabolites falls below that threshold, the result is reported as negative, even if tiny traces remain. This is one reason detection windows are ranges rather than fixed numbers: the test isn’t looking for zero, it’s looking for a concentration above a specific line.
One important quirk: standard immunoassay panels screen for benzodiazepines as a class, and alprazolam is actually one of the harder benzodiazepines for these broad screens to pick up. Not all panels reliably detect it. If a positive result occurs on the initial screen, labs typically run a confirmation test using more precise methods that can identify alprazolam and its metabolites specifically.
False Positives for Benzodiazepines
If you haven’t taken Xanax but received a positive benzodiazepine result, a few medications are known to cause false positives on immunoassay screens. The antidepressant sertraline (Zoloft) and the anti-inflammatory oxaprozin have both been documented as triggers. Sertraline in particular has been shown to cross-react with certain immunoassay techniques used in labs. A confirmation test will distinguish a true positive from a false one, so requesting confirmatory testing is the straightforward way to resolve an unexpected result.
Urine vs. Saliva Testing
Saliva (oral fluid) tests have a shorter detection window than urine. In the same controlled study that measured urine detection, saliva testing picked up alprazolam for a median of 26 hours after a single dose, with a range of 4 to 37 hours. That’s roughly 10 hours shorter than the urine window on average. Saliva tests detect the parent drug itself rather than its metabolite, which partly explains the shorter window. Urine remains the more common method for workplace and clinical screening precisely because it offers a longer lookback period.